Keyphrases
Acute Myeloid Leukemia
8%
Allogeneic Bone Marrow Transplantation
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
30%
Aplastic Anemia
9%
B Cells
9%
Bone Marrow
20%
Bone Marrow Transplantation
32%
Capillary Leak Syndrome
9%
CD8+ T Cells
8%
Childhood Cancer
9%
Chondromodulin-1
8%
Clinical Course
9%
Cyclosporine
9%
Etoposide
9%
Event-free Survival
15%
Ewing Sarcoma
90%
Ewing Sarcoma Family of Tumors
51%
EWS-FLI1
15%
Graft-versus-host Disease (GvHD)
18%
Granulocyte Colony-stimulating Factor (G-CSF)
35%
High Dose
9%
High Risk
10%
High-dose Chemotherapy
10%
HLA Matching
8%
HLA-A*02
8%
Interferon-α (IFN-α)
8%
Interleukin-10
18%
Interleukin-2
34%
Interleukin-3
8%
Interleukin-6
12%
Malignancy
16%
Melphalan
10%
Metastasis
9%
Natural Killer Cells
9%
Neuroblastoma
9%
Osteosarcoma
12%
Overall Survival
9%
Pediatric Oncology
10%
Poor Prognosis
9%
Primitive Neuroectodermal Tumor
10%
Pulmonary Alveolar Proteinosis
12%
Risk Factors
9%
Solid Tumors
11%
Soluble interleukin-2 Receptor (sIL-2R)
8%
T Cell Receptor
13%
T Cells
50%
Transgenic
18%
Tumor
29%
Tumor Cells
12%
Tumor Patients
11%
Medicine and Dentistry
Adolescent
15%
Allogeneic Stem Cell Transplantation
12%
Aplastic Anemia
9%
B Cell
10%
Bone Marrow Transplantation
28%
Cancer
10%
Cell Line
8%
Childhood Cancer
15%
Cytokine
10%
Cytotoxic T-Cell
7%
Diagnosis
9%
Disease
31%
Disease Course
8%
DNA Microarray
7%
Drug Megadose
12%
Emergency Medical Technician
11%
Etoposide
8%
Event Free Survival
15%
Ewing Sarcoma
100%
Ganglioneuroblastoma
10%
Gene Expression
7%
Granulocyte Macrophage Colony Stimulating Factor
18%
High Dose Chemotherapy
10%
HLA-A
6%
Immunotherapy
8%
In Vitro
11%
Infection
10%
Interleukin 2
10%
Lung Alveolus Proteinosis
10%
Malignant Neoplasm
6%
Melphalan
10%
Metastatic Carcinoma
14%
Neoplasm
39%
Overall Survival
11%
Pediatrics
17%
Pediatrics Patient
6%
Personalized Medicine
8%
Radiation Therapy
8%
Receptor
15%
Rhabdomyosarcoma
7%
Sarcoma
7%
Solid Malignant Neoplasm
12%
Stem Cell
14%
Stem Cell Therapy
6%
Symptom
7%
T Cell
37%
T Lymphocyte Receptor
9%
Targeted Therapy
7%
Transplantation
11%
Tumor Cell
7%
Immunology and Microbiology
Allogeneic Bone Marrow Transplantation
10%
Allogeneic Stem Cell Transplantation
12%
Aplastic Anemia
9%
Autologous Stem Cell Transplantation
5%
B Cell
16%
Bone Marrow Transplantation
27%
Capillary
9%
CD3 Antigen
8%
Cell Function
5%
Cell Line
13%
Cyclophosphamide
5%
Cytokine
25%
Cytotoxic T Cell
6%
Cytotoxic T-Cell
10%
Dendritic Cell
8%
Drug Megadose
10%
Engraftment
7%
Epigenetics
5%
Epithelial Membrane Antigen
5%
Event Free Survival
6%
Fibroblast
5%
Gene Expression
6%
Genetic Transfection
5%
Graft-Versus-Host Disease
9%
Granulocyte Colony-Stimulating Factor
5%
Granulocyte Macrophage Colony-Stimulating Factor
16%
Immunotherapy
21%
Interferon Type I
5%
Interleukin 10
11%
Interleukin 2
23%
Interleukin 2 Receptor
7%
Interleukin 3
6%
Interleukin 6
6%
Interleukin 7
7%
Monocyte
8%
Mouse
15%
Myeloid
12%
Natural Killer Cell
6%
Stem Cell
12%
T Cell
67%
T Cell Activation
6%
T Cell Receptor
16%
T-Helper Cell
6%
Transgenics
24%
Transplant Procedure
15%
Tumor Antigen
6%
Tumor Cell
12%
Tumor Cell Line
6%
Tumor Necrosis Factor
9%
Upregulation
5%
